{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:24:18Z","timestamp":1766157858455,"version":"3.48.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.nefroe.2025.501354","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T18:51:18Z","timestamp":1763232678000},"page":"501354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["GLANCE survey: awareness and implementation of the GLOSEN recommendations for the diagnosis and treatment of lupus nephritis"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0011-7706","authenticated-orcid":false,"given":"Manuel","family":"Mac\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gema","family":"Fern\u00e1ndez-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana I.","family":"\u00c1vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar","family":"Espino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Fulladosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Garc\u00eda-Carro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Goicoechea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis F.","family":"Quintana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge E.","family":"Rojas-Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Praga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefroe.2025.501354_bib0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat Rev Dis Primers."},{"year":"2011","series-title":"Systemic Lupus Erythematosus","author":"Rovin","key":"10.1016\/j.nefroe.2025.501354_bib0010"},{"key":"10.1016\/j.nefroe.2025.501354_bib0015","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","article-title":"The frequency and outcome of lupus nephritis: results from an international inception cohort study","volume":"55","author":"Hanly","year":"2016","journal-title":"Rheumatology."},{"key":"10.1016\/j.nefroe.2025.501354_bib0020","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41584-024-01158-w","article-title":"Lupus nephritis-related chronic kidney disease","volume":"20","author":"Lichtnekert","year":"2024","journal-title":"Nat Rev Rheumatol."},{"key":"10.1016\/j.nefroe.2025.501354_bib0025","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/0961203315627202","article-title":"Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis","volume":"25","author":"Lee","year":"2016","journal-title":"Lupus."},{"key":"10.1016\/j.nefroe.2025.501354_bib0030","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/ckj\/sfad055","article-title":"Diagnosis and treatment of lupus nephritis: a summary of the Consensus Document of the Spanish Group for the Study of Glomerular Diseases (GLOSEN)","volume":"16","author":"Rojas-Rivera","year":"2023","journal-title":"Clin Kidney J."},{"key":"10.1016\/j.nefroe.2025.501354_bib0035","first-page":"1","article-title":"Diagn\u00f3stico y tratamiento de la nefritis l\u00fapica. Documento de consenso del Grupo de Enfermedades Autoinmunes Sist\u00e9micas (GEAS) de la Sociedad Espa\u00f1ola de Medicina Interna (SEMI) y de la Sociedad Espa\u00f1ola de Nefrolog\u00eda (S.E.N.)","volume":"32","author":"Ruiz-Irastorza","year":"2012","journal-title":"Nefrologia"},{"key":"10.1016\/j.nefroe.2025.501354_bib0040","doi-asserted-by":"crossref","first-page":"S713","DOI":"10.1136\/annrheumdis-2020-216924","article-title":"2019 Update of the Joint European League against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of lupus nephritis","volume":"79","author":"Fanouriakis","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.nefroe.2025.501354_bib0045","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/ndt\/gfab351","article-title":"The management of lupus nephritis as proposed by EULAR\/ERA 2019 versus KDIGO 2021","volume":"38","author":"Anders","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2025.501354_bib0050","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.nefroe.2025.501354_bib0055","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2015-000123","article-title":"A proteinuria cut-off level of 0.7 g\/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial","volume":"2","author":"Tamirou","year":"2015","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.nefroe.2025.501354_bib0060","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/ki.2010.525","article-title":"Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus","volume":"79","author":"Reich","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2025.501354_bib0065","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1056\/NEJMra1604481","article-title":"Hematuria in adults","volume":"385","author":"Ingelfinger","year":"2021","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nefroe.2025.501354_bib0070","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1177\/0961203306070002","article-title":"Further description of early clinically silent lupus nephritis","volume":"15","author":"Zabaleta-Lanz","year":"2006","journal-title":"Lupus."},{"key":"10.1016\/j.nefroe.2025.501354_bib0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clim.2016.11.019","article-title":"Prognostic significance of repeat biopsy in lupus nephritis: histopathologic worsening and a short time between biopsies is associated with significantly increased risk for end stage renal disease and death","volume":"185","author":"Arriens","year":"2017","journal-title":"Clin Immunol."},{"key":"10.1016\/j.nefroe.2025.501354_bib0080","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/0961203315606985","article-title":"Renal flare prediction and prognosis in lupus nephritis Hispanic patients","volume":"25","author":"Mej\u00eda-Vilet","year":"2016","journal-title":"Lupus."},{"key":"10.1016\/j.nefroe.2025.501354_bib0085","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1191\/0961203305lu2081oa","article-title":"Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine","volume":"14","author":"Chan","year":"2005","journal-title":"Lupus."},{"key":"10.1016\/j.nefroe.2025.501354_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00041552-200501000-00002","article-title":"The role of kidney biopsy in the management of lupus nephritis","volume":"14","author":"Mittal","year":"2005","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.nefroe.2025.501354_bib0095","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1093\/ndt\/gfp359","article-title":"The clinical relevance of a repeat biopsy in lupus nephritis flares","volume":"24","author":"Daleboudt","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nefroe.2025.501354_bib0100","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.reuma.2009.09.015","article-title":"MCP-1 in urine as biomarker of renal lupus in absence of cytokines, interferon-\u03b3 and growth factors","volume":"6","author":"Barbado","year":"2010","journal-title":"Reumatol Clin (English ed)"},{"key":"10.1016\/j.nefroe.2025.501354_bib0105","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s10067-020-05454-0","article-title":"Urinary levels of ceruloplasmin and monocyte chemoattractant protein-1correlate with extra-capillary proliferation and chronic damage in patients with lupus nephritis","volume":"40","author":"Urrego-Callejas","year":"2021","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.nefroe.2025.501354_bib0110","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3390\/cells8080773","article-title":"An exosomal urinary miRNA signature for early diagnosis of renal fibrosis in lupus nephritis","volume":"8","author":"Sol\u00e9","year":"2019","journal-title":"Cells."},{"key":"10.1016\/j.nefroe.2025.501354_bib0115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22137143","article-title":"Immune-related urine biomarkers for the diagnosis of lupus nephritis","volume":"22","author":"Morell","year":"2021","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.nefroe.2025.501354_bib0120","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1681\/ASN.0000000000000365","article-title":"Immunosuppression withdrawal in patients with lupus nephritis: when, how, and for whom will it be safe?","volume":"35","author":"Frangou","year":"2024","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefroe.2025.501354_bib0125","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2023-000932","article-title":"Remission of lupus nephritis: the trajectory of histological response in successfully treated patients","volume":"10","author":"Malvar","year":"2023","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.nefroe.2025.501354_bib0130","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.kint.2019.07.018","article-title":"Kidney biopsy-based management of maintenance immunosuppression is safe and may ameliorate flare rate in lupus nephritis","volume":"97","author":"Malvar","year":"2020","journal-title":"Kidney Int."},{"issue":"24","key":"10.1016\/j.nefroe.2025.501354_bib0135","first-page":"00781","article-title":"Lupus nephritis: redefining the treatment goals","volume":"S0085-2538","author":"De Vriese","year":"2024","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2025.501354_bib0140","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJMoa2001180","article-title":"Two-year, randomized, controlled trial of belimumab in lupus nephritis","volume":"383","author":"Furie","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nefroe.2025.501354_bib0145","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0140-6736(21)00578-X","article-title":"Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"397","author":"Rovin","year":"2021","journal-title":"Lancet."},{"key":"10.1016\/j.nefroe.2025.501354_bib0150","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2024.2395451","article-title":"Efficacy and safety of biologics, multitarget therapy, and standard therapy for lupus nephritis: a systematic review and network meta-analysis","volume":"46","author":"Tian","year":"2024","journal-title":"Ren Fail."},{"key":"10.1016\/j.nefroe.2025.501354_bib0155","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.kint.2021.08.027","article-title":"A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis","volume":"101","author":"Rovin","year":"2022","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2025.501354_bib0160","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.autrev.2019.03.004","article-title":"Refractory lupus nephritis: when, why and how to treat","volume":"18","author":"Kronbichler","year":"2019","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.nefroe.2025.501354_bib0165","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1177\/0961203317749047","article-title":"Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus","volume":"27","author":"Iwata","year":"2018","journal-title":"Lupus."},{"key":"10.1016\/j.nefroe.2025.501354_bib0170","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1002\/art.20666","article-title":"Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial","volume":"50","author":"Houssiau","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.nefroe.2025.501354_bib0175","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/art.34359","article-title":"Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study","volume":"64","author":"Rovin","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.nefroe.2025.501354_bib0180","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.2215\/CJN.01070118","article-title":"Peripheral blood b cell depletion after rituximab and complete response in lupus nephritis","volume":"13","author":"Gomez Mendez","year":"2018","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefroe.2025.501354_bib0185","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1177\/0961203316641768","article-title":"Risk of clinical deterioration in patients with lupus nephritis receiving rituximab","volume":"25","author":"Manou-Stathopoulou","year":"2016","journal-title":"Lupus."},{"key":"10.1016\/j.nefroe.2025.501354_bib0190","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/annrheumdis-2014-206897","article-title":"Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis","volume":"75","author":"Tamirou","year":"2016","journal-title":"Ann Rheum Dis."}],"container-title":["Nefrolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251425001348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251425001348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:15:42Z","timestamp":1766157342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2013251425001348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2013251425001348"],"URL":"https:\/\/doi.org\/10.1016\/j.nefroe.2025.501354","relation":{},"ISSN":["2013-2514"],"issn-type":[{"type":"print","value":"2013-2514"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLANCE survey: awareness and implementation of the GLOSEN recommendations for the diagnosis and treatment of lupus nephritis","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefroe.2025.501354","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nefro.2025.501354","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"501354"}}